INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,850
0.00 (0.00%)
At close: Jun 5, 2025

INBIOGEN Revenue

INBIOGEN had revenue of 1.64B KRW in the quarter ending March 31, 2025, with 19.77% growth. This brings the company's revenue in the last twelve months to 7.31B, up 27.89% year-over-year. In the year 2024, INBIOGEN had annual revenue of 7.04B with 12.82% growth.

Revenue (ttm)
7.31B
Revenue Growth
+27.89%
P/S Ratio
16.18
Revenue / Employee
178.33M
Employees
41
Market Cap
118.32B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.04B800.26M12.82%
Dec 31, 20236.24B-4.18B-40.10%
Dec 31, 202210.42B-61.30M-0.58%
Dec 31, 202110.48B263.11M2.58%
Dec 31, 202010.22B422.51M4.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Hyundai Motor Company 178.98T
Kia Corporation 109.25T
Hyundai Mobis Co.,Ltd 58.12T
Hanjin Kal 285.07B
COWAY 4,483.23B
Hankook Tire & Technology 12.25T
Kangwon Land 1,424.80B
F&F Co., Ltd 1,894.60B
Revenue Rankings